Thom, C.S.; Chou, S.T.; French, D.L. Mechanistic and Translational Advances Using iPSC-Derived Blood Cells. Preprints2020, 2020090672. https://doi.org/10.20944/preprints202009.0672.v1
Thom, C.S., Chou, S.T., & French, D.L. (2020). Mechanistic and Translational Advances Using iPSC-Derived Blood Cells. Preprints. https://doi.org/10.20944/preprints202009.0672.v1
Thom, C.S., Stella T. Chou and Deborah L. French. 2020 "Mechanistic and Translational Advances Using iPSC-Derived Blood Cells" Preprints. https://doi.org/10.20944/preprints202009.0672.v1
Human induced pluripotent stem cell (iPSC)-based model systems can be used to produce blood cells for the study of both hematologic and non-hematologic disorders. This commentary discusses recent advances that have utilized iPSC-derived red blood cells, megakaryocytes, myeloid cells, and lymphoid cells to model hematopoietic disorders. In addition, we review recent studies that have defined how microglial cells differentiated from iPSC-derived monocytes impact neurodegenerative disease. Related translational insights highlight the utility of iPSC models for studying pathologic anemia, bleeding, thrombosis, autoimmunity, immunodeficiency, blood cancers, and neurodegenerative disease such as Alzheimer’s.
iPSC; hematopoiesis; developmental biology; anemia; thrombosis; immunodeficiency; cancer
Biology and Life Sciences, Anatomy and Physiology
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.